Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Post by blinkieon Dec 19, 2020 9:14pm
278 Views
Post# 32148214

Shareswapper I Love Your Posts BUT ....

Shareswapper I Love Your Posts BUT ....First of all Thank You for taking the time to educate us all regarding rge Drug research and everything related to it surrounding ICO.  Your depth of knowledge makes me very humble..

I am guilty of mainly being involved with ICO as an Investment opportunity.  I like many others may not share yours & others passion.

Allow me to respectively state the fact that withile the Doctor (an Insider) purchased 800,ooo+ his actual capital investment of $40-$50,000 is not life shattering money.  Or even a large financial risk.

I am not claiming personally that i kaveri that kind of "chang" lying around.

I just really want to believe that there is a fairly quick and potential gates that might help all us shareholders a path to financial gains !
<< Previous
Bullboard Posts
Next >>